相关实验视频

Updated: Jul 17, 2025

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

重组抗体碎片用于神经疾病:最新情况

Karen Manoutcharian¹, Goar Gevorkian¹

¹Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM), CDMX, Mexico.

Current neuropharmacology

|August 30, 2023

概括

重组抗体碎片显示出治疗神经退行性疾病的前景,如阿尔茨海默氏症和帕金森氏症. 这些碎片提供了新的治疗策略和穿越血脑屏障的潜力.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

再组合抗体碎片 (例如,Fab,scFv,sdAbs,bsAbs) 正在成为全长抗体的替代品.
使用抗体的免疫治疗已在各种神经退行性疾病的临床前模型中证明有效.

研究的目的:

审查用于神经退行性疾病治疗的重组抗体片段的最新进展.
探索这些碎片的新应用和血脑屏障透策略.

主要方法:

对复合抗体碎片的临床前和临床研究的文献综述.
对神经系统疾病的治疗疗效和输送方法的分析.

主要成果:

一些抗体碎片正在针对阿尔茨海默病 (AD),帕金森病 (PD) 和多发性硬化症 (MS) 进行研究.
已批准的疗法包括阿杜卡努马布和莱卡内马布治疗阿尔茨海默病,突出显示了基于抗体的治疗的潜力.

结论:

再组合抗体碎片为开发神经退行性疾病的新疗法提供了重大机会.
进一步研究血脑屏障的穿越和有针对性的分娩对于临床翻译至关重要.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.亨廷顿病是亨廷顿氏病的一种疾病.一个纳米人体.帕金森病是帕金森氏症的一种疾病.抗体碎片的部分.免疫疗法. 免疫疗法.在人体内,人体内.

更多相关视频

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on: June 29, 2016

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...